Name | Titel |
Seit |
Hong Kong Exchanges and Clearing Limited (Betreiber von Finanz- und Rohstoffmärkten) |
Independent Non-Executive Director |
2021 |
Zai Lab Limited (Pharmazeutika) |
Director |
2014 |
CanSino Biologics Inc. (Pharmazeutika) |
Non-Executive Director |
2015 |
Qiming Venture Partners Ltd. |
Managing Partner |
2009 |
Pacific Advantage (International) Ltd. |
Director |
- |
Shenogen Pharma Group Ltd. |
Director |
- |
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. |
Director |
2016 |
Zhejiang Nurotron Nerve Electronic Technology Co Ltd |
Director |
2014 |
New Horizon Health Sciences Co. Ltd. |
Director |
2018 |
Hangzhou New Horizon Health Technology Co., Ltd. |
Director |
2017 |
Nurotron Biotechnology, Inc. |
Director |
- |
Qiming Development Hk Ltd. |
Partner |
2007 |